Genetically Engineered T Cells Could Lead to Therapies for Autoimmune Diseases

Dec. 3, 2020

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.